GlassScriptPhysician profile
Kenneth A Turk
NPI 1366434375
$849.52
in general payments reported to CMS, 2019-2025
19 companies · $45.59 in 2025
The $45.59 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $81.96 · 2021: $67.85 · 2022: $40.51 · 2023: $111 · 2024: $85.68 · 2025: $45.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $131.22 | 2019-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Pfizer INC. | $115.09 | 2019 | |
| Ironshore Pharmaceuticals INC. | $108.07 | 2019-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $69.61 | 2019-2021 | |
| Neos Therapeutics, LP | $68.32 | 2019-2025 | Cotempla Xr-Odt |
| Glaxosmithkline, LLC. | $52.93 | 2019-2020 | |
| Kaleo, INC. | $46.70 | 2020-2024 | Auvi-Q |
| Adlon Therapeutics L.P. | $40.21 | 2019-2020 | |
| Avion Pharmaceuticals | $31.15 | 2023 | Methylphenidate Hydrochloride |
| Phadia US INC. | $28.21 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $24.03 | 2022 | |
| Vertical Pharmaceuticals, LLC | $22.32 | 2025 | Relexxii |
| Roche Diagnostics Corporation | $18.64 | 2019 | |
| Corium, LLC | $17.48 | 2024 | Azstarys |
| Tris Pharma INC | $16.48 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $16.25 | 2019 | |
| Novo Nordisk INC | $15.81 | 2024 | Wegovy |
| Sanofi Pasteur INC. | $14.28 | 2024 | |
| Sobi, INC | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Turk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.